Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 Synthetic API
    • 1.1.2.2 Biotech API
    • 1.1.2.3 Others
  • 1.1.3 Market by Application
    • 1.1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • 1.1.3.2 Oncology Drugs
    • 1.1.3.3 Anti-diabetic Drugs
    • 1.1.3.4 Cardiovascular Drugs
    • 1.1.3.5 Central Nervous System Drugs (CNS Drugs)
    • 1.1.3.6 Musculoskeletal Drugs
    • 1.1.3.7 Other Drugs
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 Teva
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 Novartis
• 6.3 Pfizer
• 6.4 Johnson & Johnson
• 6.5 Mylan
• 6.6 North China Pharmaceutical Group
• 6.7 Dr. Reddy’s Laboratories
• 6.8 Roche
• 6.9 Aurobindo pharma
• 6.10 Sun Pharmaceutical Industries
• 6.11 Boehringer Ingelheim GmbH
• 6.12 Bayer
• 6.13 BASF
• 6.14 DSM
• 6.15 Zhejiang Medicine
• 6.16 Biocon
• 6.17 Johnson Matthey
• 6.18 Hisun Pharmacy
• 6.19 Cambrex
• 6.20 Shandong Xinhua Pharmaceutical
• 6.21 Lonza group
• 6.22 Huahai Pharmaceutical
• 6.23 Haerbin Pharmaceutical Group
• 6.24 Cipla
• 6.25 Tian Yao
• 6.26 Lupin
• 6.27 North East Pharmaceutical
• 6.28 Albemarle
• 6.29 Shandong Lukang Pharmaceutical
• 6.30 Jiangsu Hengrui Medicine
• 6.31 Bachem

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion

Summary
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
Market Segment as follows:
By Type
Synthetic API
Biotech API
Others
By Application
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs
By Company
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Bachem
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.